Cargando…
Positron Emission Intensity in the Decay of (86g)Y for Use in Dosimetry Studies
The β(+)-emitting radionuclide (86g)Y (t(1/2) = 14.7 h) forms a matched-pair with the β(−)-emitting therapeutic radionuclide (90)Y (t(1/2) = 2.7 d) for theranostic application in medicine. This approach demands a precise knowledge of the positron emission probability of the PET nuclide which was unt...
Autores principales: | Uddin, M. Shuza, Qaim, Syed M., Scholten, Bernhard, Basunia, M. Shamsuzzoha, Bernstein, Lee A., Spahn, Ingo, Neumaier, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839740/ https://www.ncbi.nlm.nih.gov/pubmed/35164033 http://dx.doi.org/10.3390/molecules27030768 |
Ejemplares similares
-
Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review
por: Hussain, Mazhar, et al.
Publicado: (2023) -
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair (86)Y and (90)Y
por: Rösch, Frank, et al.
Publicado: (2017) -
Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy
por: Wurzer, Alexander, et al.
Publicado: (2017) -
Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers
por: Garrow, Adam A., et al.
Publicado: (2020) -
Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023)